Ka. Hunt et Ea. Sickles, Effect of obesity on screening mammography: Outcomes analysis of 88,346 consecutive examinations, AM J ROENTG, 174(5), 2000, pp. 1251-1255
Citations number
34
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
OBJECTIVE. We determined differences in the rates of recall, biopsy, and ca
ncer detection for screening mammography as a function of adiposity.
MATERIALS AND METHODS. Eighty-eight thousand three hundred forty-six consec
utive screening mammography examinations were performed from April 1985 to
August 1997. Patient weights were normalized to ideal weight correcting for
height and were subdivided into adiposity cohorts including underweight by
greater than 10%; ideal weight +/- 10%; overweight by 11-24%; overweight b
y 25-39%; and overweight by greater than 40%. The rates of recall, biopsy,
cancer detection, and cancer stage were calculated and were analyzed using
the chi-square test for trend. Cancer size was analyzed using linear regres
sion analysis.
RESULTS. Reliable (p < 0.05) and meaningful differences were seen between c
ohorts of increasing adiposity for rates of recall, biopsy, and cancer dete
ction. An increase in recall rate occurred with progressively increasing ad
iposity (3.88%, 4.89%, 5.11%, 5.47%, 5.55% [p < 0.0001]). The rate of biops
y also increased with increasing adiposity (0.98%, 1.31%, 1.35%, 1.59%, 1.6
5% [p < 0.0002]), as did the rate of screening-detected cancer (number of c
ases of cancer per 1000 women screened) (3.74, 4.29, 5.34, 4.70, 6.04 [p <
0.015]). Finally, increased adiposity also correlated with increased median
cancer size (p < 0.02) and with more advanced stage at diagnosis (p = 0.04
6).
CONCLUSION. increasing adiposity correlates with progressive increases in t
he rates of recall, biopsy, and cancer detection for women undergoing scree
ning mammography. Increasing adiposity also correlates with increased cance
r size and stage, providing further support for obesity as a risk factor fo
r breast cancer.